Skip to main content
TrialFinder
ResourcesAbout
ⓘNot medical advice.▾

This site is for general information only and is not medical advice, diagnosis, or treatment. Always talk to a qualified clinician before medical decisions. TrialFinder is not affiliated with trial sponsors or healthcare providers.

Privacy policyTerms of useAccessibilityFAQFeedback
Support the project (opens in a new tab)

We use functional cookies to improve your experience. See our Privacy policy.

Trial data comes from ClinicalTrials.gov (US) and is shown for information only.

In memory of Dov Korn ❤️

Start Here: Search Clinical Trials | TrialFinder
HomeResourcesStart Here: How to Search for Clinical Trials on TrialFinder

Back to Resources

Published · May 26, 2026· Updated September 18, 2026

Start Here: How to Search for Clinical Trials on TrialFinder

You have a diagnosis, and someone mentioned clinical trials. Or maybe you found your way here on your own. Either way, you're in the right place.

TrialFinder is a free, non-profit tool that helps patients and families search for clinical trials worldwide. The data comes from publicly available registries, and the interface is designed to be usable without any medical background. This guide walks you through how to get the most out of it.

Start with the condition name

The search bar is the starting point. Type the name of the condition you're looking for, and TrialFinder will return matching trials.

Keep it simple. Don't type full sentences like "stage 4 lung cancer with brain metastases." Instead, type the primary condition: lung cancer, melanoma, ALS, Crohn's disease. The system will pull all relevant trials, and you can narrow things down from there.

If the molecular report names a less common EGFR change, there is a separate guide to osimertinib and uncommon EGFR mutations.

If you're not sure where to start, you can also tap one of the common condition shortcuts below the search bar, such as Lung Cancer, Breast Cancer, or Leukemia, to jump straight into results without typing.

You can search in English or Hebrew. TrialFinder translates medical terms between the two languages automatically, so you'll get accurate results either way. If you're not sure about the English name of a condition, type it in Hebrew and the system will handle the mapping.

TrialFinder also keeps track of your recent searches so you can pick up where you left off. By default, these are only stored for your current session. If you want them to persist between visits, toggle on "Remember searches on this device", but keep in mind that anyone with access to the device will be able to see them.

Or upload your medical summary

If you have a visit summary, discharge letter, or oncology note as a PDF or photo, you can use Upload medical summary below the search bar instead of typing everything yourself. You can also paste clinical text directly.

Processing happens on your device first: text is extracted (including OCR for scanned PDFs), then common personal identifiers are removed. Only scrubbed text is sent for AI-assisted extraction. You review and edit what was understood—stage, biomarkers, prior treatments, and more—before it updates your search and eligibility hints.

Automated redaction is not perfect. Use the scrubbed preview and edit any field before confirming. See our Privacy Policy for details.

Use the filters to narrow your results

After searching, you'll see a list of trials and a set of filters to refine it. Here's what each one does:

Geographic scope. Three options: All (trials anywhere in the world), Israel only, or Outside Israel. Start with "All" to see the full picture. If you're specifically looking for something you can do locally, switch to "Israel only."

Trial phase. You can filter by Phase 1, 2, 3, or 4. If you're not sure what these mean, here's the short version: Phase 1 tests safety and dosing. Phase 2 tests whether the drug works. Phase 3 compares the new treatment against the current standard. Phase 4 monitors long-term effects after approval. For a deeper explanation, see Key Clinical Trial Terms.

Actively recruiting toggle. When this is on, you'll only see trials that are currently accepting patients. When it's off, you'll also see trials that may not be recruiting right now but are still worth knowing about.

How to navigate your results

If you got too many results: Turn on the "actively recruiting" toggle and pick a geographic scope that works for you. This will cut the list down to what's actionable right now.

If you got too few results, or none at all: Loosen the filters. Switch geographic scope back to "All." Turn off the recruiting toggle. A trial that isn't recruiting today might open up next month. A trial in another country might still be relevant, and your doctor can sometimes arrange participation across borders, or the same drug might be available through a Compassionate Use program.

Understand the trial in plain language

When you open a trial page, you'll see the raw protocol data: titles, conditions, interventions, all in medical English. This can be overwhelming. That's where the AI summary comes in.

Tap the "Generate summary" button on any trial page, and TrialFinder will create a plain-language breakdown of what the trial is about, what it's testing, and what participation involves. The summary is generated by AI and is not a substitute for medical advice, but it can help you quickly understand whether a trial is worth discussing with your doctor.

At the bottom of each trial page, Similar trials shows other recruiting studies that may be relevant based on condition, treatment, phase, or location. Use it to compare options without going back to search.

Check the eligibility criteria

Every trial has strict entry requirements. When you open a trial page, look at the inclusion and exclusion criteria. These will tell you things like: which disease stages are eligible, which prior treatments are required or disqualifying, what lab values or performance scores are needed.

On the same trial page, TrialFinder also offers a Quick eligibility check. Answer a few questions about your situation and you will get an early sense of whether the trial might be a fit. It is a helper, not a medical decision, and it does not replace the research team's official screening.

Don't self-disqualify too fast. If a trial looks promising but you're not sure if you meet the criteria, bring it to your doctor. They can read the protocol and tell you whether it's worth pursuing.

If you applied and got a "no," read Not a Perfect Match? Tips for Getting Into a Clinical Trial Anyway. There are more options than you might think.

What to do next

The best next step after finding a trial that interests you is a conversation with your treating physician. Bring the trial's NCT number (the unique ID you'll see on each trial page) and the eligibility summary. A prepared patient makes for a faster, more productive conversation.

If you want to reach out yourself, some trial pages list a study team email. Look for "Contact study team (email)" on the trial page. You can also generate a summary first, then use "Draft email to study team" in the action center to open a pre-filled message. You can also copy a shareable summary from there to send your doctor via WhatsApp or email. Not every trial publishes a contact address, and sending an email does not guarantee a response or enrollment, but when contact details are available it is a direct way to ask whether the trial is still recruiting.

If you're new to the world of clinical trials entirely, start with What is a Clinical Trial? for context on how the process works and what to expect. When you have a specific trial in mind, read Before You Join a Clinical Trial for screening, informed consent, questions to ask, and red flags.

Have feedback on TrialFinder or this guide? I'd love to hear from you. Send feedback.

Related conditions

Lymphoma Clinical Trials: How Subtype and Treatment History Shape Eligibility Understand Hodgkin and non-Hodgkin lymphoma, biopsy results, and prior treatment, then find clinical trials to discuss with a hematologist.

Colorectal (Colon) Cancer Clinical Trials: Colon vs Rectal, MSI Status, and Prior Treatment Understand colon and rectal cancer stage, MSI/dMMR, KRAS, NRAS, BRAF and HER2 results, and prior treatment, then find clinical trials to discuss with an oncologist.

Long COVID Clinical Trials: Finding Studies for POTS, Fatigue, and Cognitive Symptoms Long COVID is not one condition. POTS, fatigue with PEM, and cognitive symptoms open different trial lists.

Melanoma Clinical Trials: Stage, BRAF Status, and What You Already Tried Melanoma trials are written for a specific stage, BRAF status, and treatment history. Learn what separates one study from another and how to search recruiting trials.

Alzheimer's Disease Clinical Trials: Stage, Amyloid and Tau, and What It Means for Family Alzheimer's is not one trial population. Stage and biomarkers such as amyloid and tau shape which studies may fit.

Further reading

Osimertinib for Uncommon EGFR Mutations: What the Evidence Shows Osimertinib (Tagrisso) for uncommon EGFR mutations such as G719X, S768I, L861Q, and exon 20 insertions: what the evidence covers, plus active clinical trials.

Clinical Trials in Mental Health: What Patients and Families Should Know Mental health clinical trials may test medication, therapy, or devices. How they differ from cancer trials, and how to start looking.

Before You Join a Clinical Trial: Screening, Informed Consent, and Red Flags Learn what screening and informed consent involve before you join a clinical trial, which questions to ask, and which red flags mean you should walk away.

The Reminder Moderna and Merck's Personalized mRNA Cancer Vaccine Gives Us About Clinical Trials Moderna and Merck's personalized mRNA vaccine met Phase 3 goals in melanoma. What that shows about joining a clinical trial.

Daraxonrasib (RASONQUE) Is Now FDA-Approved for Metastatic Pancreatic Cancer

AML (Acute Myeloid Leukemia) Clinical Trials: FLT3, IDH, NPM1, and New vs Relapsed
Leukemia is not one disease. How FLT3, IDH, and NPM1 mutations, and newly diagnosed vs relapsed acute myeloid leukemia, change which trials may fit.

Epilepsy Clinical Trials: Seizure Type, and What Comes Next When Medicines Stop Working Seizure type, epilepsy syndrome, and whether medicines have stopped working decide which epilepsy trials may fit. Recruiting studies included.

Brain Tumor Clinical Trials: Glioblastoma, Lower-Grade Glioma, and Recurrence Glioblastoma or lower-grade glioma, new or recurrent, IDH and MGMT status: what separates one brain tumor trial from another. Recruiting studies included.

Breast Cancer Clinical Trials: HR+, HER2+ or Triple-Negative, and Why Subtype Comes First HR+, HER2+ or triple-negative, plus BRCA and PIK3CA results: how your subtype points to different breast cancer trials. Recruiting studies included.

Pancreatic Cancer Clinical Trials: Resectable or Metastatic, and Why KRAS Matters Resectable or metastatic, KRAS, BRCA or MSI: how each detail changes which pancreatic cancer trials may fit. Recruiting studies included.

Lung Cancer Clinical Trials: EGFR, ALK, KRAS, and Small-Cell vs Non-Small-Cell Small-cell or non-small-cell, EGFR, ALK or KRAS: how each result changes which lung cancer trials may fit. Recruiting studies included.

The FDA approved daraxonrasib (RASONQUE) on August 26, 2026 for metastatic pancreatic cancer after prior therapy.

How to Talk to Your Doctor About Clinical Trials What questions should you ask your doctor about clinical trials? A step-by-step guide for patients: when to bring it up, what to prepare, and what to do after.

What is a Clinical Trial? (It's More Than You Think) How clinical trials work, why they matter, and what patients should know before considering one.

Not a Perfect Match? Tips for Getting Into a Clinical Trial Anyway A rejection from a clinical trial doesn't have to be the end. Practical tips for patients and caregivers who hit a wall.

How to Talk About Clinical Trials with a Family Member A guide for caregivers on introducing clinical trials to a loved one who is hesitant, tired, or afraid.

Key Clinical Trial Terms Plain-language explanations of terms patients and families encounter during the clinical trial process.

Share this post
  •  

This article was written by a patient advocate based on personal experience, not by a medical professional. It is not medical advice. Consult your doctor before making any medical decisions.

Looking for a clinical trial?

Search trials